We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin (NUS) Shines on Solid Sales Leaders & Customer Network
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) appears to be in robust shape. Its focus on empowering sales leaders and strengthening the customer base, with effective product launches and engaging technology platforms, has been working well for the company. These factors keep Nu Skin well-placed amid challenges related to COVID-19.
Focus on Product Launches – a Long-Term Strategy
The company’s long-term strategies stand on three key pillars: Products, Programs and Platforms. The launch of NUS’ revolutionary ageLOC LumiSpa, along with the re-launch of the Galvanic Spa device, has been a success. Management is also impressed with the rollout of Nutricentials Bioadaptives, a customizable skincare line targeted at millennials and Gen Z. In a recent update, management highlighted that it is impressed with the launch of Collagen+ in the United States amid pandemic-inflicted disruptions. In the third quarter, the company’s top line partly benefited from continued growth in the United States due to the Beauty Focus Collagen+ launch. The company stated that it will focus on expanding ageLOC META and Collagen+ across markets during the fourth quarter. Apart from product launches, Nu Skin’s well-knit product strategies and customer retention programs have been driving growth in several market locations.
Image Source: Zacks Investment Research
Empowering Sales Leaders & Solidifying Customer Base
Nu Skin sells and distributes products through a network of sales leaders and customers. The company remains focused on empowering them through product launches and engaging technology platforms among other initiatives. Moreover, the company has been conducting several promotional seminars online. Additionally, Nu Skin rolled out its Velocity sales compensation plan as well as the enJoy rewards program over the past three years. These programs are doing well and continuing to aid growth in sales leaders and customers. The company is also expanding the social commerce training for its leaders. During the third quarter of 2021, the company benefited from double-digit growth in Korea, driven by product promotions and sales leader initiatives.
A shift to work-from-home and at-home personal care trends has led to increased online shopping, which presents a unique opportunity for the company’s business. With these macro trends, Nu Skin is making significant investments in the digital platform to build a socially enabled business. NUS is on track to become a disruptive beauty and wellness leader via three key transformational strategies. The company is developing innovative products and leveraging its key position in beauty device systems. It is planning to launch next-generation connected devices beginning in 2022. Further, management is transforming its business with the help of robust social commerce and distinctive person-to-person affiliate marketing channel for creating more brand awareness as well as acquiring customers at a higher rate. Lastly, the company’s focus on building a robust digital ecosystem to enhance customer attraction bodes well. The digital platform accounts for more than 90% of the company’s revenues.
Nu Skin is set to keep its splendid show going with its abovementioned growth endeavors. This Zacks Rank #2 (Buy) stock has rallied 28.5% in the past three months compared with the industry’s rise of 1.1%.
Helen of Troy, a designer, developer, marketer, importer and distributor, carries a Zacks Rank #1 (Strong Buy) at present. Shares of Helen of Troy have dipped 1.1% in the past three months. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Helen of Troy’s current financial-year sales and earnings per share (EPS) suggests growth of 0.8% and 0.6%, respectively, from the year-ago reported number. HELE has a trailing four-quarter earnings surprise of 19.1%, on average.
The Estee Lauder Companies, which manufactures, markets and sells skincare, makeup, fragrance and hair care products, carries a Zacks Rank #2 at present. Shares of The Estee Lauder Companies have moved up 2.2% in the past three months.
The Zacks Consensus Estimate for The Estee Lauder Companies’ current financial-year sales and EPS suggests growth of 15.5% and 15.2%, respectively, from the year-ago reported number. EL has a trailing four-quarter earnings surprise of 37%, on average.
Medifast, the manufacturer and distributor of weight loss, weight management, healthy living products, and other consumable health and nutritional products, currently carries a Zacks Rank #2. Shares of Medifast have risen 2.5% in the past three months.
The Zacks Consensus Estimate for Medifast’s current financial-year sales and EPS suggests growth of about 63% and 49.3%, respectively, from the year-ago reported figure. MED has a trailing four-quarter earnings surprise of 17.3%, on average.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Nu Skin (NUS) Shines on Solid Sales Leaders & Customer Network
Nu Skin Enterprises, Inc. (NUS - Free Report) appears to be in robust shape. Its focus on empowering sales leaders and strengthening the customer base, with effective product launches and engaging technology platforms, has been working well for the company. These factors keep Nu Skin well-placed amid challenges related to COVID-19.
Focus on Product Launches – a Long-Term Strategy
The company’s long-term strategies stand on three key pillars: Products, Programs and Platforms. The launch of NUS’ revolutionary ageLOC LumiSpa, along with the re-launch of the Galvanic Spa device, has been a success. Management is also impressed with the rollout of Nutricentials Bioadaptives, a customizable skincare line targeted at millennials and Gen Z. In a recent update, management highlighted that it is impressed with the launch of Collagen+ in the United States amid pandemic-inflicted disruptions. In the third quarter, the company’s top line partly benefited from continued growth in the United States due to the Beauty Focus Collagen+ launch. The company stated that it will focus on expanding ageLOC META and Collagen+ across markets during the fourth quarter. Apart from product launches, Nu Skin’s well-knit product strategies and customer retention programs have been driving growth in several market locations.
Empowering Sales Leaders & Solidifying Customer Base
Nu Skin sells and distributes products through a network of sales leaders and customers. The company remains focused on empowering them through product launches and engaging technology platforms among other initiatives. Moreover, the company has been conducting several promotional seminars online. Additionally, Nu Skin rolled out its Velocity sales compensation plan as well as the enJoy rewards program over the past three years. These programs are doing well and continuing to aid growth in sales leaders and customers. The company is also expanding the social commerce training for its leaders. During the third quarter of 2021, the company benefited from double-digit growth in Korea, driven by product promotions and sales leader initiatives.
A shift to work-from-home and at-home personal care trends has led to increased online shopping, which presents a unique opportunity for the company’s business. With these macro trends, Nu Skin is making significant investments in the digital platform to build a socially enabled business. NUS is on track to become a disruptive beauty and wellness leader via three key transformational strategies. The company is developing innovative products and leveraging its key position in beauty device systems. It is planning to launch next-generation connected devices beginning in 2022. Further, management is transforming its business with the help of robust social commerce and distinctive person-to-person affiliate marketing channel for creating more brand awareness as well as acquiring customers at a higher rate. Lastly, the company’s focus on building a robust digital ecosystem to enhance customer attraction bodes well. The digital platform accounts for more than 90% of the company’s revenues.
Nu Skin is set to keep its splendid show going with its abovementioned growth endeavors. This Zacks Rank #2 (Buy) stock has rallied 28.5% in the past three months compared with the industry’s rise of 1.1%.
Hot Consumer Staple Bets
Some other top-ranked stocks are Helen of Troy (HELE - Free Report) , The Estee Lauder Companies Inc. (EL - Free Report) and Medifast, Inc. (MED - Free Report)
Helen of Troy, a designer, developer, marketer, importer and distributor, carries a Zacks Rank #1 (Strong Buy) at present. Shares of Helen of Troy have dipped 1.1% in the past three months. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Helen of Troy’s current financial-year sales and earnings per share (EPS) suggests growth of 0.8% and 0.6%, respectively, from the year-ago reported number. HELE has a trailing four-quarter earnings surprise of 19.1%, on average.
The Estee Lauder Companies, which manufactures, markets and sells skincare, makeup, fragrance and hair care products, carries a Zacks Rank #2 at present. Shares of The Estee Lauder Companies have moved up 2.2% in the past three months.
The Zacks Consensus Estimate for The Estee Lauder Companies’ current financial-year sales and EPS suggests growth of 15.5% and 15.2%, respectively, from the year-ago reported number. EL has a trailing four-quarter earnings surprise of 37%, on average.
Medifast, the manufacturer and distributor of weight loss, weight management, healthy living products, and other consumable health and nutritional products, currently carries a Zacks Rank #2. Shares of Medifast have risen 2.5% in the past three months.
The Zacks Consensus Estimate for Medifast’s current financial-year sales and EPS suggests growth of about 63% and 49.3%, respectively, from the year-ago reported figure. MED has a trailing four-quarter earnings surprise of 17.3%, on average.